Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
7th grade Good
|
New words:
accelerated, accredited, advisory, affixed, aggregate, attended, attributed, bazedoxifene, Biological, Cambrex, cap, channel, CLL, compensation, conservative, consideration, Contin, daily, data, declared, dividend, Duragesic, estimate, estimated, Executive, external, hinder, inconsistent, inside, Institute, institutional, interferon, Intron, investor, Janssen, judged, Kadian, lasofoxifene, leukemia, low, lymphocytic, Medicare, mitigated, moving, Nasdaq, National, negatively, negotiate, NHL, Nipent, offering, ONTAK®and, ONTAK®decreased, ONTAK®in, Oramorph, OxyContin, Panretin®gel, Phamaceutical, Pharmaceutica, pharmacy, PIND, practice, Purdue, Purepac, Ratification, Raylo, removed, request, resale, retail, rotation, routinely, Roxane, RP, Rule, Salk, Scherer, sensor, slower, SR, switch, threatened, tort, toxic, transaction, transferee, type, uncommon, uneconomic, unregistered, withdrew
Filing tables
Filing exhibits
LGND similar filings
External links